findmyKOL
Clinical trialNCT05383274RecruitingPhase 4Interventional

Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters

SponsorUrotronic Inc.Enrollment34Urethral Stricture
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Single-arm, prospective study assessing semen quality after treatment with the Optilume Urethral DCB in men between 22 and 65 years of age.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Arkansas Urology

    Little Rock, Arkansas, United States

    Recruiting
  • Orlando Health

    Orlando, Florida, United States

    Recruiting
  • Florida Urology

    Tampa, Florida, United States

    Recruiting
  • Regional Urology

    Shreveport, Louisiana, United States

    Completed
  • Chesapeake

    Hanover, Maryland, United States

    Completed
  • Freedman Urology

    Las Vegas, Nevada, United States

    Recruiting
  • New Jersey Urolgy

    Millburn, New Jersey, United States

    Completed
  • Western New York

    Cheektowaga, New York, United States

    Recruiting
  • Urology Clinics of North Texas

    Dallas, Texas, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Feb 2022
Primary completion
30 Jun 2026
Completion
30 Dec 2026
Last update posted
28 Apr 2026
Registered enrollment
34
Registry id
NCT05383274

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.